Despite what you hear from social media influencers about the importance of maintaining muscle mass when taking Ozempic, he says, for most people, this isnt a problem that needs to be solved. That view is supported by clinical trials on GLP-1 drugs
Since the drug was undetectable in milk at all time points tested (0, 12, and 24 hours post-dose for semaglutide), there is no peak concentration period to avoid
Comparing GLP-1s with sodium-glucose cotransporter-2 (SGLT-2) inhibitors, they found the weight loss injections both reduced the risk of addiction in people with no previous history and reduced adverse outcomes and deaths in those who already had a diagnosed substance use disorder
Oshi Health
Expanding the use of GLP-1 receptor agonists across obesity, cardiovascular disease, chronic kidney disease, MASH, and other metabolic disorders requires manufacturers to generate robust long-term clinical evidence for each therapeutic indication
doi: 10.1530/JOE-13-0393 72 YanHYangWZhouFLiXPanQShenZet al